Diabetes Therapeutics Market with COVID-19 Impact Analysis, By Therapy Type (Oral Antidiabetics, Injectable Antidiabetics, Others), By Diseases (Type 1 diabetes, Type 2 diabetes, Gestational diabetes), By End User (Hospitals and Clinics, Homecare, others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Diabetes Therapeutics Market size was valued at USD 97,200 Million in 2022, expanding at a CAGR of 5.9 % from 2023 to 2030.
Diabetes therapies refer to a wide variety of medical treatments and interventions used to manage diabetes mellitus, a chronic metabolic condition characterized by elevated blood sugar levels. These medications are intended to assist diabetics control their blood glucose levels, avoid problems, and enhance their general quality of life. Diabetes treatment options may involve food and activity adjustments, as well as oral medicines, injectable insulin, and other pharmacological treatments. Continuous monitoring, education, and patient participation are critical components of diabetes treatments for achieving glycemic control, lowering the risk of complications, and promoting long-term health and well-being in diabetics.
Diabetes Therapeutics Market- Market Dynamics
- Global rise in diabetes prevalence propels market demand
The rising prevalence of type 1 and type 2 diabetes, which is typically linked to factors such as sedentary lifestyles, poor diets, and obesity, causes a growing need for effective therapies. Diabetes diagnoses and problems are increasing, putting strain on healthcare systems throughout the globe. This motivates pharmaceutical firms and researchers to create new therapies such as enhanced insulin formulations, innovative oral drugs, and cutting-edge technology like as continuous glucose monitoring and artificial pancreas systems. Combating the diabetes pandemic is a top healthcare concern.
Diabetes Therapeutics Market- Key Insights
- As per the analysis shared by our research analyst, the global Diabetes Therapeutics market is estimated to grow annually at a CAGR of around 5.9% over the forecast period (2023-2030)
- The Diabetes Therapeutics industry is projected to grow at a significant rate due to global rise in diabetes prevalence.
- Based on Therapy Type segmentation, Oral Antidiabetics was predicted to show maximum market share in the year 2022
- Based on Diseases segmentation, Gestational diabetes was the leading Therapy Type in 2022
- On the basis of region, Asia Pacific was the leading revenue generator in 2022
Diabetes Therapeutics Market- Segmentation Analysis:
The Global Diabetes Therapeutics Market is segmented on the basis of Therapy Type, Diseases, End User, and Region.
The market is divided into three categories based on Therapy Type: Oral Antidiabetics, Injectable Antidiabetics, Others. The Oral Antidiabetics dominates the market. The demand for oral antidiabetics in diabetes therapeutics is significant. These drugs, which are often in the form of pills or tablets, are commonly used to assist people with type 2 diabetes in managing their blood sugar levels. They are a crucial component of oral treatment, assisting in glucose control and lowering the risk of complications.
The market is divided into three categories based on Diseases: Type 1 diabetes, Type 2 diabetes, Gestational diabetes. The Gestational diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. Diabetes treatments are in high demand among pregnant women with gestational diabetes. Its goal is to control blood sugar levels in pregnant women who acquire diabetes throughout their pregnancy. To protect the health of both the mother and the growing foetus, therapeutic treatments may include dietary changes, exercise, insulin therapy, or other drugs.
Diabetes Therapeutics Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Diabetes medicines are in high demand in the Asia-Pacific area as a result of numerous converging causes. For starters, the area is seeing an increase in diabetes prevalence, which is being driven by urbanization, sedentary lifestyles, and dietary changes. Second, the rising burden of diabetes and its effects is exacerbated by an ageing population. Third, better healthcare infrastructure and expanded access to healthcare services have boosted diabetes management awareness. Finally, cultural and genetic variables influence the frequency of diabetes subtypes. The Asia-Pacific pharmaceutical industry and healthcare providers are being pushed to create and offer effective treatments to address this important public health crisis.
Diabetes Therapeutics Market- Competitive Landscape:
Diabetes medicines have a vibrant competitive environment that includes both major pharmaceutical behemoths and upstart biotech enterprises. Companies such as Novo Nordisk, Sanofi, and Eli Lilly are important competitors in the insulin business, producing and selling a broad variety of insulin treatments, injectable GLP-1 receptor agonists, and oral diabetes drugs. In addition, device makers like as Dexcom and Medtronic provide continuous glucose monitoring systems and insulin delivery devices to the market. Ongoing research on innovative medicines like as SGLT-2 inhibitors and initiatives to produce more patient-friendly insulin delivery methods characterise the landscape. Diabetes care is improving as a result of competition, as are patient outcomes and the worldwide burden of this chronic illness.
Recent Developments:
- In July 2023, Better Therapeutics, Inc. reported that the Food and Drug Administration (FDA) has approved AspyreRx (previously BT-001), a prescription-only digital therapeutic (PDT) medication recommended to offer cognitive behavioral therapy to type 2 diabetes (T2D) patients aged 18 and older.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIABETES THERAPEUTICS MARKET KEY PLAYERS
- Astrazeneca PLC
- Boehringer Ingelheim GmbH
- Eli Lilly and Company
- GlaxoSmithKline PLC
- Novartis AG
- Novo Nordisk
- Sanofi SA
- Takeda Pharmaceutical Company Limited
- Johnson and Johnson Md&D
- Merck and Co. Inc.
GLOBAL DIABETES THERAPEUTICS MARKET, BY THERAPY TYPE
- Oral Antidiabetics
- Injectable Antidiabetics
- Others
GLOBAL DIABETES THERAPEUTICS MARKET, BY DISEASES
- Type 1 diabetes
- Type 2 diabetes
- Gestational diabetes
GLOBAL DIABETES THERAPEUTICS MARKET, BY END USER
- Hospitals and Clinics
- Homecare
- others
GLOBAL DIABETES THERAPEUTICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Diabetes Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Diabetes Therapeutics Market Snippet by Diseases
2.1.2. Diabetes Therapeutics Market Snippet by Therapy Type
2.1.3. Diabetes Therapeutics Market Snippet by End User
2.1.4. Diabetes Therapeutics Market Snippet by Country
2.1.5. Diabetes Therapeutics Market Snippet by Region
2.2. Competitive Insights
3. Diabetes Therapeutics Key Market Trends
3.1. Diabetes Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Diabetes Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Diabetes Therapeutics Market Opportunities
3.4. Diabetes Therapeutics Market Future Trends
4. Diabetes Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Diabetes Therapeutics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Diabetes Therapeutics Market Landscape
6.1. Diabetes Therapeutics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Diabetes Therapeutics Market – By Diseases
7.1. Overview
7.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
7.1.2. Type 1 diabetes
7.1.3. Type 2 diabetes
7.1.4. Gestational diabetes
8. Diabetes Therapeutics Market – By Therapy Type
8.1. Overview
8.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
8.1.2. Oral Antidiabetics
8.1.3. Injectable Antidiabetics
8.1.4. Others
9. Diabetes Therapeutics Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
9.1.2. Hospitals and Clinics
9.1.3. Homecare
9.1.4. others
10. Diabetes Therapeutics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Diabetes Therapeutics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Diabetes Therapeutics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Diabetes Therapeutics Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Diabetes Therapeutics Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Diabetes Therapeutics Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Diabetes Therapeutics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Astrazeneca PLC
11.2.2. Boehringer Ingelheim GmbH
11.2.3. Eli Lilly and Company
11.2.4. GlaxoSmithKline PLC
11.2.5. Novartis AG
11.2.6. Novo Nordisk
11.2.7. Sanofi SA
11.2.8. Takeda Pharmaceutical Company Limited
11.2.9. Johnson and Johnson Md&D
11.2.10. Merck and Co. Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
